Lew D - Search Results

1

Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study.

Williamson SK, Lew D, Miller GJ, Balcerzak SP, Baker LH, Crawford ED. Williamson SK, et al. Among authors: lew d. Cancer. 2000 Mar 1;88(5):1159-65. Cancer. 2000. PMID: 10699907 Clinical Trial.

2

Phase II trial of edatrexate in relapsed or refractory germ cell tumors: a Southwest Oncology Group study (SWOG 9124).

Meyers FJ, Lew D, Lara PN Jr, Williamson S, Marshall E, Balcerzak SP, Rivkin SE, Samlowski W, Crawford ED. Meyers FJ, et al. Among authors: lew d. Invest New Drugs. 1998-1999;16(4):347-51. doi: 10.1023/a:1006128024879. Invest New Drugs. 1998. PMID: 10426670 Clinical Trial.

3

Southwest Oncology Group Study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: the importance of survival as a clinical trial end point.

Small EJ, Lew D, Redman BG, Petrylak DP, Hammond N, Gross HM, Eastham JA, Crawford ED. Small EJ, et al. Among authors: lew d. J Clin Oncol. 2000 Jul;18(13):2537-44. doi: 10.1200/JCO.2000.18.13.2537. J Clin Oncol. 2000. PMID: 10893284 Clinical Trial.

4

Phase II trial of recombinant human interleukin-4 in patients with advanced renal cell carcinoma: a southwest oncology group study.

Whitehead RP, Lew D, Flanigan RC, Weiss GR, Roy V, Glode ML, Dakhil SR, Crawford ED. Whitehead RP, et al. Among authors: lew d. J Immunother. 2002 Jul-Aug;25(4):352-8. doi: 10.1097/00002371-200207000-00007. J Immunother. 2002. PMID: 12142558 Clinical Trial.

5

Phase II evaluation of suramin in advanced renal cell carcinoma. A Southwest Oncology Group study.

Schroder LE, Lew D, Flanigan RC, Eisenberger MA, Seay TE, Hammond N, Needles BM, Crawford ED. Schroder LE, et al. Among authors: lew d. Urol Oncol. 2001 Jul;6(4):145-148. doi: 10.1016/s1078-1439(00)00126-5. Urol Oncol. 2001. PMID: 11418320

6

Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501.

Velasquez WS, Lew D, Grogan TM, Spiridonidis CH, Balcerzak SP, Dakhil SR, Miller TP, Lanier KS, Chapman RA, Fisher RI; Southwest Oncology Group. Velasquez WS, et al. Among authors: lew d. J Clin Oncol. 2003 May 15;21(10):1996-2003. doi: 10.1200/JCO.2003.09.047. J Clin Oncol. 2003. PMID: 12743154 Clinical Trial.

7

Infusional interleukin-2 and 5-fluorouracil with subcutaneous interferon-alpha for the treatment of patients with advanced renal cell carcinoma: a southwest oncology group Phase II study.

Elias L, Lew D, Figlin RA, Flanigan RC, Thompson ME, Triozzi PL, Belt RJ, Wood DP Jr, Rivkin SE, David E. Elias L, et al. Among authors: lew d. Cancer. 2000 Aug 1;89(3):597-603. Cancer. 2000. PMID: 10931459 Clinical Trial.

8

A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338.

Chew HK, Barlow WE, Albain K, Lew D, Gown A, Hayes DF, Gralow J, Hortobagyi GN, Livingston R. Chew HK, et al. Among authors: lew d. Clin Breast Cancer. 2008 Dec;8(6):511-5. doi: 10.3816/CBC.2008.n.062. Clin Breast Cancer. 2008. PMID: 19073506 Free PMC article. Clinical Trial.

9

Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.

Rivkin SE, Green SJ, Lew D, Costanzi JJ, Athens JW, Osborne CK, Vaughn CB, Martino S. Rivkin SE, et al. Among authors: lew d. Cancer. 2003 Jan 1;97(1):21-9. doi: 10.1002/cncr.10982. Cancer. 2003. PMID: 12491501 Free article. Clinical Trial.

10

Evaluation of Tomudex in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group study.

Samlowski WE, Lew D, Kuebler PJ, Kolodziej MA, Medina JE, Mangan KF, Moore DF Jr, Schuller DE, Ensley JF. Samlowski WE, et al. Among authors: lew d. Invest New Drugs. 1998-1999;16(3):271-4. doi: 10.1023/a:1006178808095. Invest New Drugs. 1998. PMID: 10360608 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

816 results

Search Page

Filters